# Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer

> **NCT04049227** · EARLY_PHASE1 · COMPLETED · sponsor: **Northwestern University** · enrollment: 27 (actual)

## Conditions studied

- Endometrial Endometrioid Adenocarcinoma

## Interventions

- **DRUG:** Abemaciclib
- **DRUG:** Letrozole
- **PROCEDURE:** Therapeutic Conventional Surgery

## Key facts

- **NCT ID:** NCT04049227
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-12
- **Primary completion:** 2023-04-01
- **Final completion:** 2023-05-15
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2025-10-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04049227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04049227, "Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04049227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*